AI assistant
Arcadia Biosciences, Inc. — Director's Dealing 2016
Feb 4, 2016
35424_dirs_2016-02-03_d1c04fa3-0d3c-4062-b455-7cc37e355588.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2016-02-01
Reporting Person: Rey Eric J. (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-02-01 | Common Stock | S | 3000 | $2.9313 | Disposed | 140380 | Direct |
| 2016-02-03 | Common Stock | S | 200 | $2.78 | Disposed | 140180 | Direct |
Footnotes
F1: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan adopted by the Reporting Person effective December 14, 2015.
F2: This transaction was executed in multiple trades at prices ranging from $2.80 to $3.05. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: Includes 750 shares acquired under the Issuer's 2015 Employee Stock Purchase Plan on February 1, 2016.